Zobrazeno 1 - 4
of 4
pro vyhledávání: '"59"'
Autor:
Andrea Browatzki, Helene Priemé, Therese S. Lapperre, Oliver Djurhuus Tupper, Pradeesh Sivapalan, Ida Steffensen, Christian Søborg, Casper Tidemandsen, Tor Biering-Sørensen, Dorthe Høgsberg, Jens-Ulrik Stæhr Jensen, Muhzda Ghanizada, Daniel Bech Rasmussen, Peter Lange, Uffe Bodtger, Asger Sverrild, Vibeke Gottlieb, Christina Marisa Bergsoe, Sidse Graff Jensen, Josefin Eklöf, Jens D Lundgren, Tobias Wirenfeldt Klausen, Martin Steen Frydland, Eva Brøndum, Alexander Jordan, Kjell Erik Julius Håkansson, Lars Egholm Pedersen, Charlotte Suppli Ulrik, Jon Torgny Wilcke, Howraman Meteran, Rasmus Dahlin Bojesen, Filip K. Knop
Publikováno v:
The European Respiratory Journal
article-version (AM) Accepted Manuscript
Sivapalan, P, Suppli Ulrik, C, Sophie Lapperre, T, Dahlin Bojesen, R, Eklöf, J, Browatzki, A, Torgny Wilcke, J, Gottlieb, V, Julius Håkansson, K E, Tidemandsen, C, Tupper, O, Meteran, H, Bergsøe, C, Brøndum, E, Bodtger, U, Bech Rasmussen, D, Graff Jensen, S, Pedersen, L, Jordan, A, Priemé, H, Søborg, C, Steffensen, I E, Høgsberg, D, Wirenfeldt Klausen, T, Steen Frydland, M, Lange, P, Sverrild, A, Ghanizada, M, Krag Knop, F, Biering-Sørensen, T, Lundgren, J D, Stæhr Jensen, J-U & ProPAC-COVID study group 2022, ' Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19 : a randomised double-blinded placebo-controlled trial ', European Respiratory Journal, vol. 59, no. 1, 2100752 . https://doi.org/10.1183/13993003.00752-2021
Sivapalan, P & ProPAC-COVID writing group on behalf of the ProPAC-COVID Study Group 2022, ' Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19 : a randomised double-blinded placebo-controlled trial ', European Respiratory Journal, vol. 59, no. 1, 2100752 . https://doi.org/10.1183/13993003.00752-2021
article-version (AM) Accepted Manuscript
Sivapalan, P, Suppli Ulrik, C, Sophie Lapperre, T, Dahlin Bojesen, R, Eklöf, J, Browatzki, A, Torgny Wilcke, J, Gottlieb, V, Julius Håkansson, K E, Tidemandsen, C, Tupper, O, Meteran, H, Bergsøe, C, Brøndum, E, Bodtger, U, Bech Rasmussen, D, Graff Jensen, S, Pedersen, L, Jordan, A, Priemé, H, Søborg, C, Steffensen, I E, Høgsberg, D, Wirenfeldt Klausen, T, Steen Frydland, M, Lange, P, Sverrild, A, Ghanizada, M, Krag Knop, F, Biering-Sørensen, T, Lundgren, J D, Stæhr Jensen, J-U & ProPAC-COVID study group 2022, ' Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19 : a randomised double-blinded placebo-controlled trial ', European Respiratory Journal, vol. 59, no. 1, 2100752 . https://doi.org/10.1183/13993003.00752-2021
Sivapalan, P & ProPAC-COVID writing group on behalf of the ProPAC-COVID Study Group 2022, ' Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19 : a randomised double-blinded placebo-controlled trial ', European Respiratory Journal, vol. 59, no. 1, 2100752 . https://doi.org/10.1183/13993003.00752-2021
Background Combining the antibiotic azithromycin and hydroxychloroquine induces airway immunomodulatory effects, with the latter also having in vitro antiviral properties. This may improve outcomes in patients hospitalised for COVID-19. Methods Place
Autor:
Michael Kreuter, Andreas Günther, Klaus F. Rabe, Juergen Behr, Carmen Schade-Brittinger, Jasmin Wagner, Antje Prasse, Petra Neuser
Publikováno v:
Clinical Problems Others.
Pirfenidone is approved in the EU for the treatment of mild to moderate Idiopathic Pulmonary Fibrosis (IPF), but not for other forms of progressive fibrotic lung diseases, in which anti-inflammatory therapy is not sufficiently effective. RELIEF, a ra
Autor:
Antonio Anzueto, Antoni Torres, Carles Agustí, Eva Polverino, Josep Mensa, Oriol Sibila, Michael S. Niederman, Rosario Menéndez, Miquel Ferrer, Jacobo Sellares, Marcos I. Restrepo, Albert Gabarrus
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
Intensive Care Medicine
Dipòsit Digital de la UB
Universidad de Barcelona
instname
Intensive Care Medicine
Dipòsit Digital de la UB
Universidad de Barcelona
Importance In patients with severe community-acquired pneumonia, treatment failure is associated with excessive inflammatory response and worse outcomes. Corticosteroids may modulate cytokine release in these patients, but the benefit of this adjunct
Autor:
Gina Eagle, John P. McGinnis, Liza Micioni, Kenneth N. Olivier, Richard J. Wallace, Barbara A. Brown-Elliott
Publikováno v:
10.1 Respiratory Infections.
Aim: AMK MICs and mutational resistance were evaluated in patients with NTM-LD who received LAI, a novel AMK formulation. Methods: In the 84-day double-blind (DB) phase, patients received nebulized LAI 590 mg QD or placebo (PBO) added to their ongoin